Effects of aromatase inhibitor therapy on adiposity and cardiometabolic health in postmenopausal women: a controlled cohort extension study

Purpose: We previously demonstrated that 12 months of aromatase inhibitor (AI) treatment was not associated with a difference in body compositi on or other markers of cardiometabolic health when compared to controls. Here we report on the pre-planned extension of the study. The pre-specified primary...

Full description

Bibliographic Details
Main Authors: Yee-Ming M Cheung, Rudolf Hoermann, Karen Van, Damian Wu, Jenny Healy, Bella Halim, Manjri Raval, Maria McGill, Ali Al-Fiadh, Michael Chao, Shane White, Belinda Yeo, Jeffrey D Zajac, Mathis Grossmann
Format: Article
Language:English
Published: Bioscientifica 2023-09-01
Series:Endocrine Connections
Subjects:
Online Access:https://ec.bioscientifica.com/view/journals/ec/12/10/EC-23-0076.xml